Entera Bio Retained Earnings Over Time
| ENTX Stock | USD 1.59 0.03 1.85% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Entera Bio Performance and Entera Bio Correlation. Entera |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.26) | Revenue Per Share 0.003 | Quarterly Revenue Growth (0.92) | Return On Assets (0.71) | Return On Equity (1.45) |
The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Entera Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Retained Earnings Analysis
Compare Entera Bio and related stocks such as NLS Pharmaceutics, Vaccinex, and Alterity Therapeutics Retained Earnings Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NLSP | (16.3 M) | (16.3 M) | (16.3 M) | (16.3 M) | (16.3 M) | (16.3 M) | (16.3 M) | (16.3 M) | (21.5 M) | (26.9 M) | (29.8 M) | (41.7 M) | (58.2 M) | (70.4 M) | (66.9 M) |
| VCNX | (168.5 M) | (168.5 M) | (168.5 M) | (168.5 M) | (168.5 M) | (168.5 M) | (168.5 M) | (187.2 M) | (216.8 M) | (248.6 M) | (277.5 M) | (299.9 M) | (319.7 M) | (339.9 M) | (356.9 M) |
| ATHE | (11 M) | (90.1 M) | (97.9 M) | (111.3 M) | (117.1 M) | (124.9 M) | (122.6 M) | (129.6 M) | (141.2 M) | (151 M) | (169.7 M) | (181.9 M) | (195.1 M) | (214.2 M) | (203.5 M) |
| IMMP | (35.9 M) | (99.7 M) | (115 M) | (128.3 M) | (160.5 M) | (222.5 M) | (231.8 M) | (244.6 M) | (262.2 M) | (275.7 M) | (274.6 M) | (302.3 M) | (339.9 M) | (382.6 M) | (363.5 M) |
Entera Bio and related stocks such as NLS Pharmaceutics, Vaccinex, and Alterity Therapeutics Retained Earnings description
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.My Equities
My Current Equities and Potential Positions
| Entera Bio | ENTX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Israel |
| Exchange | NASDAQ Exchange |
USD 1.59
Additional Tools for Entera Stock Analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.